ArticleAnnals of translational medicine2022

Somatic mutations combined with clinical features can predict the postoperative prognosis of stage IIIA lung adenocarcinoma.

Jiuzhen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.